Accelowave Technologies

A new standard for Swallowing Health

Accelowave is building a non-invasive motion-sensing platform that turns subtle throat and body-reference signals into structured, clinically meaningful data, the foundation for a more objective way to assess how someone swallows.

Concept visualization of a clinician fitting the Aspirometer neck band on an older adult, with the sternum reference sensor positioned on skin and connected by a cable with a coiled center section
Aspirometer™Proprietary data collection
AI-PoweredMachine-learning analysis
Objective DataActionable insights
The opportunity

Bringing objective insight to critical, hidden movement.

Swallowing happens in under a second, largely hidden from sight. Clinicians have long relied on what they can see and hear at the bedside, which means that subtle, but critical movement patterns often go unnoticed. Accelowave's Aspirometer™ technology is built to capture and analyze that movement directly, at the point of care.

01
Abstract profile visualization making a subtle throat motion trace visible

Patterns that are hard to see

Biomechanical movement patterns of swallowing unfold in seconds. External sensing gives that motion a permanent, reviewable record instead of a fleeting impression.

02
Abstract two-point visualization comparing throat motion with an upper-sternum body reference

Context changes everything

Swallowing movement can be obscured by breathing and body motion when using a single sensor. A second reference point separates swallow-specific signals from surrounding noise.

03
Abstract motion signals passing through a machine-learning pattern lens and emerging as a highlighted event ready for human review

From signal to decision

Accelowave's long-term vision is to pair captured motion with machine-learning analysis trained on a clinically labeled dataset, turning raw signals into actionable insight.

The commercial platform

Aspirometer™ connects sensing, software, and intelligence.

The Aspirometer™ pairs a non-invasive wearable with software built for clinical workflow. Each session captures a structured, individual measurement of swallow-related motion.

Commercial Aspirometer wearable concept with a primary throat module, adjustable neck band, sternum reference sensor, and one cable with an elastic coiled center
Aspirometer™ sensor technology

Designed for simple, repeatable capture

A compact primary throat sensor and upper-sternum reference sensor work together to measure subtle swallowing movement with body motion context.

Branded white tablet interface concept showing a single measurement, a motion-capture trace, recording status, and new-measurement and export controls using artificial demo data
Connected software

One measurement, clearly presented

The companion interface is envisioned to bring guided capture, signal quality, and analysis into one focused workflow.

01
Dual-point sensing

Throat and body-reference motion, captured together for context.

02
Connected workflow

Guided capture, quality status, and organized session review.

03
Machine-learning pathway

Today, each measurement is a standalone, individual assessment. Longitudinal baseline tracking and per-patient analysis are planned as a future platform capability.

Commercial product vision. Capabilities shown are under development and subject to validation and regulatory review.

Commercial Aspirometer packaging concept showing the finished throat module, sternum reference sensor, coiled-center cable, neck band, storage case, and documentation arranged in a fitted presentation tray
Commercial packaging concept. Final packaging, contents, labeling, and materials remain subject to development and review.
Forward thinking design

A platform built for expansion.

The Aspirometer™ is designed to improve as the underlying model learns from more data collected across the population it serves. Each measurement today is a standalone, individual assessment; longitudinal, per-patient tracking is a future capability as the platform matures.

  • Data is the foundation.

    Every session records the motion metrics that will train tomorrow's analysis.

  • Machine-learning, applied.

    Future ML tools are being built to compare data across sessions, refine individual baselines, and track progress against clinical goals.

  • Room to specialize.

    As the platform is validated, condition-specific algorithms could help surface patterns earlier, before they'd otherwise be caught.

Concept visualization of an elderly patient in a light blue medical gown taking a supervised sip while wearing the Aspirometer throat and sternum sensors, with a clinician holding a tablet
Product vision

From reliable signal capture to validated clinical intelligence.

Current Alpha-stage work focuses on a reliable sensing and data foundation. Wireless operation, a clinician-friendly handheld device, and validated clinical interpretation are future development steps.

NOW
Engineering Alpha

Dual-sensor capture, normalized motion, session records, and export.

NEXT
Connected workflow

MVP device production and ML-analysis tools.

FUTURE
Validated clinical layer

Clinical-grade processing, performance validation, and regulatory review.

Momentum

Recognized for the vision. Building the foundation.

Accelowave has earned recognition and support from national aging-research, health-innovation, and university venture programs, funding and validating the technology while the team builds toward clinical trials and regulatory review.

Accelowave co-founders in a professional team portrait
January 29, 2026

NIA Start-Up Challenge winner

Selected as a national winner following a multi-stage aging-innovation accelerator and pitch program.

Program source
Accelowave team members receiving second place at Pitt's Big Idea competition
April 11, 2025

Second place in Pitt's Big Idea competition

Recognition for the team's vision, customer discovery, and path toward commercialization.

Program source
Accelowave team members at the Pitt SHRS Innovation Challenge
March 21, 2024

First place in the SHRS Innovation Challenge

An early milestone supporting continued product development and commercialization work.

Program source
Leadership

Clinical insight, engineering depth, and company-building experience.

Accelowave brings together leaders in swallowing science, clinical care, biomedical signal processing, and commercialization.

Amanda Mahoney
Chief Executive Officer

Amanda Mahoney, PhD, CCC-SLP

Speech-language pathologist and business leader guiding strategy, funding, and commercialization.

LinkedIn
Erin Lucatorto
Chief Scientific Officer

Erin Lucatorto, PhD, CCC-SLP

Swallowing-disorders researcher guiding scientific direction and sensor-driven assessment research.

LinkedIn
Jim Coyle
Chief Medical Officer

Jim Coyle, PhD, CCC-SLP

Clinician, researcher, and educator with decades of expertise in swallowing physiology and dysphagia care.

LinkedIn
Ervin Sejdic
Chief Technology Officer

Ervin Sejdic, PhD

Biomedical engineer and entrepreneur specializing in signal processing, machine learning, and health technology.

LinkedIn
Build the next chapter with us

Help shape a more measurable future for swallowing health.

We're building relationships with investors, strategic partners, and clinical innovators who see the same gap we do, and want to help close it.